Pantolactams as Androgen Receptor Antagonists for the Topical Suppression of Sebum Production

    Karen Elaine Sexton, Stephen Barrett, Katy L. Bridgwood, Matthew Carroll, Danielle Dettling, Daniel K. Du, Stephen A. Fakhoury, Victor Fedij, Lain-Yen Hu, Catherine R. Kostlan, David Pocalyko, N. Raheja, Yvonne E. Smith, Veerabahu Shanmugasundaram, Kimberly Jane Wade
    Image of study
    TLDR Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.
    In 2011, Pfizer Global Research & Development conducted a study to identify potent androgen receptor (AR) antagonists that could suppress sebum production when applied topically. They discovered that pantolactam-based compounds were effective AR antagonists. When tested in the Hamster Ear Model, these compounds reduced wax esters, a major component of sebum, leading to further preclinical work. The study also revealed that all AR antagonist activity was found in the (+)-isomer for the pantolactams. Two compounds, 48 and 50, were chosen for additional preclinical studies due to their effectiveness in reducing sebum production.
    Discuss this study in the Community →

    Cited in this study

    9 / 9 results